Absolute Lymphocyte Count on Day 30 Is a Surrogate for Robust Hematopoietic Recovery and Strongly Predicts Outcome after T Cell-Depleted Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 10, 2007, Pages 1216-1223

  Savani, Bipin N ^a   Mielke, Stephan ^a   Rezvani, Katayoun ^a   Montero, Aldemar ^a   Yong, Agnes S ^a   Wish, Laura ^a   Superata, Jeannine ^a   Kurlander, Roger ^b   Singh, Anurag ^c   Childs, Richard ^a   Barrett, A John ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ALL; Allogeneic stem cell transplantation; AML; CML; Day 30 lymphocyte count

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; DONOR LYMPHOCYTE INFUSION; DRUG BLOOD LEVEL; ENGRAFTMENT; FEMALE; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELOABLATIVE CONDITIONING; NEUTROPHIL; OUTCOMES RESEARCH; PREDICTION; RISK ASSESSMENT; SCHOOL CHILD; SIBLING; T CELL DEPLETION; THROMBOCYTE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; COHORT STUDIES; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE COUNT; MALE; NEOPLASM RECURRENCE, LOCAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDICTIVE VALUE OF TESTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548680962     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.07.005     Document Type: Article

References (19)

1. Powles R., Singhal S., Treleaven J., et al. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood 91 (1998) 3481-3486
2. Kim D.H., Kim J.G., Sohn S.K., et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol 125 (2004) 217-224
3. Kumar S., Chen M.G., Gastineau D.A., et al. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant 28 (2001) 951-956
4. Chakrabarti S., Brown J., Guttridge M., et al. Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback. Bone Marrow Transplant 32 (2003) 23-30
5. Einsele H., Ehninger G., Steidle M., et al. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 82 (1993) 1672-1678
6. Lee K.H., Choi S.J., Lee J.H., et al. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Haematologica 90 (2005) 939-948
7. Savani B.N., Rezvani K., Mielke S., et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 107 (2006) 1688-1695
8. Niederwieser D., Gastl G., Rumpold H., et al. Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT). Br J Haematol 65 (1987) 301-305
9. Jiang Y.Z., Barrett A.J., Goldman J.M., and Mavroudis D.A. Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation. Ann Hematol 74 (1997) 1-6
10. Sconocchia G., del P.D., and Barrett A.J. Non-classical antileukemia activity of early recovering NK cells after induction chemotherapy and HLA-identical stem cell transplantation in myeloid leukemias. Leukemia 20 (2006) 1632-1633
11. Montero A., Savani B.N., Shenoy A., et al. T cell depleted peripheral blood stem cell allotransplantation with T cell add back for patients with hematological malignancies: effect of chronic GVHD on outcome. Biol Blood Marrow Transplant 12 (2006) 1318-1325
12. Saliba R.M., Komanduri K.V., Giralt S., et al. Correlates and outcome of absolute lymphocyte count (ALC) on day 30 post allogeneic stem cell transplantation (SCT) for treatment of AML. Biol Blood Marrow Transplant 13 2(Suppl 2) (2007) 98
13. Talmadge J.E., Reed E., Ino K., et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 19 (1997) 161-172
14. Roberts M.M., To L.B., Gillis D., et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 12 (1993) 469-475
15. Anderson K.C., Ritz J., Takvorian T., et al. Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow. Blood 69 (1987) 597-604
16. Reittie J.E., Gottlieb D., Heslop H.E., et al. Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. Blood 73 (1989) 1351-1358
17. Savani B.N., Mielke S., Rezvani K., et al. Total lymphocyte and natural killer (NK) cell count day 30 post-transplant strongly predict transplant outcome after T cell depleted allogeneic stem cell transplantation. ASH Annu Meet Abstr 108 (2006) 2993
18. Scholl S., Mugge L.O., Issa M.C., et al. Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT. Bone Marrow Transplant 35 (2005) 183-190
19. Ruggeri L., Mancusi A., Burchielli E., et al. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol 19 (2007) 142-147